05:10 PM EDT, 07/08/2024 (MT Newswires) -- MDB Capital ( MDBH ) said Monday it is collaborating with the Mayo Clinic to develop a small molecule anti-senescence platform for advancing research in longevity and age-related disease prevention.

The partnership is through a patent and know-how agreement, according to MDB Capital ( MDBH ).

Financial terms of the collaboration were not disclosed.